Skip to main content
Equibles

MDNA · Medicenna Therapeutics Corp.

Use MDNA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MDNA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
0.4400 CAD +0.0400 (+10.00%) At close · Nov 6 Intraday price with Plus
Rebalance outlook locked

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Investor day
Close0.4400 CAD Open0.4450 CAD Day0.4350–0.4500 CAD 52W close0.3450–1.6400 CAD Avg vol 30d52K DataJan 2020–Nov 2026

Latest documents

2026
All documents

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Price context
position in its 52-week range
Range low 0.3450 CAD Now 0.4400 CAD · 7% Range high 1.6400 CAD
vs 200-day avg -19% vs 50-day avg +2%

Illustrative technical + ownership context — a signal mix, not investment advice.

Performance

5D 20D 120D MTD YTD
XTSE:MDNA -3.3% -1.1% -21.4% -3.3% -52.2%

Exchange listing

Market
XTSE
Ticker
MDNA
ISIN
—
Security
Ordinary share
Trading currency
CAD

Company with tickers: MDNAF

Company

Website
https://www.medicenna.com/
Investor relations
https://ir.medicenna.com/

Other listings of this company

Share classes and depositary receipts can have different prices and dividends.

Latest price

Plus & Pro

Follow MDNA during the session: the latest price, the day's change, range and volume. Closing prices stay free.

View plans Sign in

Recent dividends

No verified dividend payments are available for this listing yet.

Upcoming investor events

No upcoming investor events are listed for this company yet.

Earnings calls

No earnings calls have been captured for this company yet.